Literature DB >> 9762818

Frequency of pre-existing actinic keratosis in cutaneous squamous cell carcinoma.

M A Mittelbronn1, D L Mullins, F A Ramos-Caro, F P Flowers.   

Abstract

BACKGROUND: Controversy over the rate of malignant transformation of actinic keratosis (AK) into cutaneous squamous cell carcinoma (SCC) has generated considerable debate regarding the importance of treating all such precancers to preclude their transofrmation. Current changes in US healthcare policy will deny many individuals access to certain simple and effective treatment modalities for precancerous lesions.
OBJECTIVE: Our purpose was to determine whether there is a significant association between the presence of cutaneous SCC and pre-existing AK.
METHODS: One hundred and sixty five consecutive cases of cutaneous SCC, retrieved from the files of a university-affiliated dermatopathology laboratory serving north-central Florida, were selected for review by a single dermatopathologist (D.M.). Hematoxylin and eosin stained skin tissue slides were examined under light microscopy for the presence of AK in close proximity to, or giving rise to, cutaneous SCC.
RESULTS: Of the 165 cutaneous SCC cases reviewed, 82.4% (136 out of 165) were found to have concomitant AK giving rise to and/or in close proximity to SCC. Of the 136 AK-positive SCC cases, 26.7% (44) were identified as superficial SCC arising within an AK (AKSSCC) and 55.7% (92) had AK in close proximity to SCC (AK + SCC). Close proximity is defined to include AK changes located directly adjacent to (on the shoulder of) SCC, to a maximum distance of 8 mm away.
CONCLUSIONS: The 82.4% prevalence of concomitant AK and cutaneous SCC in our biopsy population suggests a strong correlation between these two lesions. The fact that 26.7% of these lesions had SCC arising from AK highlights the importance of early recognition and effective treatment for AK.

Entities:  

Mesh:

Year:  1998        PMID: 9762818     DOI: 10.1046/j.1365-4362.1998.00467.x

Source DB:  PubMed          Journal:  Int J Dermatol        ISSN: 0011-9059            Impact factor:   2.736


  31 in total

1.  Topical imiquimod therapy for actinic keratosis: is long-term clearance a realistic benefit?

Authors: 
Journal:  J Clin Aesthet Dermatol       Date:  2008-09

2.  Actinic keratosis treatment as a key component of preventive strategies for nonmelanoma skin cancer.

Authors:  Joel L Cohen
Journal:  J Clin Aesthet Dermatol       Date:  2010-06

3.  Selenium unmasks protective iron armor: A possible defense against cutaneous inflammation and cancer.

Authors:  Jack L Arbiser; Michael Y Bonner; Nicole Ward; Justin Elsey; Shikha Rao
Journal:  Biochim Biophys Acta Gen Subj       Date:  2018-05-28       Impact factor: 3.770

4.  Tolerability of Ingenol Mebutate Gel, 0.05%, for Treating Patients with Actinic Keratosis on the Scalp in a Community Dermatology Practice.

Authors:  Miriam S Bettencourt
Journal:  J Clin Aesthet Dermatol       Date:  2016-03-01

5.  Tolerability and Pharmacokinetics of Ingenol Mebutate 0.05% Gel Applied to Treatment Areas up to 100cm(2) on the Forearm(s) of Patients with Actinic Keratosis.

Authors:  Lawrence Anderson; Michael Jarratt; George Schmieder; Stephen Shumack; Janelle Katsamas; Peter Welburn
Journal:  J Clin Aesthet Dermatol       Date:  2014-12

Review 6.  From keratinocyte to cancer: the pathogenesis and modeling of cutaneous squamous cell carcinoma.

Authors:  Vladimir Ratushny; Michael D Gober; Ryan Hick; Todd W Ridky; John T Seykora
Journal:  J Clin Invest       Date:  2012-02-01       Impact factor: 14.808

7.  The impact of the current United States guidelines on the management of actinic keratosis: is it time for an update?

Authors:  George Martin
Journal:  J Clin Aesthet Dermatol       Date:  2010-11

8.  Fluorouracil cream 0.5% for the treatment of actinic keratoses on the face and anterior scalp: interim results of an 18-month open-label study.

Authors:  Dow Stough; Alicia D Bucko; George Vamvakias; Elyse S Rafal; Steven A Davis
Journal:  J Clin Aesthet Dermatol       Date:  2008-07

9.  In-office Painless Aminolevulinic Acid Photodynamic Therapy: A Proof of Concept Study and Clinical Experience in More Than 100 Patients.

Authors:  George M Martin
Journal:  J Clin Aesthet Dermatol       Date:  2016-02

10.  Are keratoacanthomas variants of squamous cell carcinomas? A comparison of chromosomal aberrations by comparative genomic hybridization.

Authors:  Ole Petter F Clausen; Hans Christian D Aass; Marzieh Beigi; Karin J Purdie; Charlotte M Proby; Victoria L Brown; Morten Mattingsdal; Francesca Micci; Steen Kølvraa; Lars Bolund; Paula M Deangelis
Journal:  J Invest Dermatol       Date:  2006-05-25       Impact factor: 8.551

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.